Zimmer Biomet Holdings, Inc.

NYSE:ZBH

105.73 (USD) • At close September 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 7,678.67,394.26,939.96,827.36,127.57,982.27,932.97,803.37,668.45,997.84,673.34,623.44,471.74,451.84,220.24,095.44,121.13,897.53,495.43,286.12,980.91,9011,372.41,178.61,040.6939861
Cost of Revenue 2,191.22,083.82,019.51,960.41,824.32,252.62,271.92,132.92,381.81,800.61,242.81,286.11,125.21,1221,012.2990.7997.3875.9780.1739.4779.9516.2344.8325.9290.9269265
Gross Profit 5,487.45,310.44,920.44,866.94,303.25,729.65,6615,670.45,286.64,197.23,430.53,337.33,346.53,329.83,2083,104.73,123.83,021.62,715.32,546.72,2011,384.81,027.6852.7749.7670596
Gross Profit Ratio 0.7150.7180.7090.7130.7020.7180.7140.7270.6890.70.7340.7220.7480.7480.760.7580.7580.7750.7770.7750.7380.7280.7490.7230.720.7140.692
Reseach & Development Expenses 437.4458.7406435.8322.8449.3391.7369.9365.6268.8191.9204.2225.6238.4218.5205.7192.3209.6188.3175.5166.7105.880.771.6524536
General & Administrative Expenses 0000003,379.33,369.72,944.62,660.51,978.21,833.81,912.31,863.51,7661,7641,77300000000394349
Selling & Marketing Expenses 0000000-2650000000000000000000
SG&A 2,929.82,838.92,761.72,843.42,712.73,343.83,379.33,104.72,944.62,660.51,978.21,833.81,912.31,863.51,7661,7641,7731,489.71,355.71,259.61,190737.5546532.8429.7394349
Other Expenses 834.5735.11,056.4727.41,184.67991,856.21,396.51,155.3800.6223.16161.2203.8306.8116.268.5194.76.156.681.190.800000
Operating Expenses 4,201.74,032.74,224.14,006.64,220.14,592.15,627.24,871.14,465.53,729.92,393.22,0382,299.12,305.72,291.32,085.92,033.81,8941,550.11,491.71,437.8934.1626.7604.4481.7439385
Operating Income 1,285.71,277.7696.3860.383.11,137.533.8799.3821.1467.31,037.31,035.61,047.41,024.1916.71,018.81,0901,127.61,165.21,055763.2450.7400.9248.3268231211
Operating Income Ratio 0.1670.1730.10.1260.0140.1430.0040.1020.1070.0780.2220.2240.2340.230.2170.2490.2640.2890.3330.3210.2560.2370.2920.2110.2580.2460.245
Total Other Income Expenses Net -249.1-210.4-292.8-361.3-188.3-231.7-304.9-334.7-421.5-314.1-97.9-87.5-57.3-45.2-56.5-20.631.843.8-14.3-31.7-13.2-12-7.4000
Income Before Tax 1,036.61,067.3403.5499-105.2905.8-271.1464.6399.6153.2939.4981.1990.1978.9860.2998.21,121.81,131.61,1691,040.7731.5437.5388.9240.9268231211
Income Before Tax Ratio 0.1350.1440.0580.073-0.0170.113-0.0340.060.0520.0260.2010.2120.2210.220.2040.2440.2720.290.3340.3170.2450.230.2830.2040.2580.2460.245
Income Tax Expense 131.442.2112.353.5-96-225.7108.2-1,348.8957220.2221.9237.2218.9263.3280.8272.3357.9334307.3189.6146.8131.191.1928166
Net Income 903.81,024231.4401.6-138.91,131.6-379.21,813.8305.9147720.3761755760.8596.9717.4848.6773.2834.5732.5541.8346.3257.8149.8176150145
Net Income Ratio 0.1180.1380.0330.059-0.0230.142-0.0480.2320.040.0250.1540.1650.1690.1710.1410.1750.2060.1980.2390.2230.1820.1820.1880.1270.1690.160.168
EPS 4.454.911.391.93-0.665.52-1.869.111.510.274.264.494.324.062.983.343.733.283.432.962.221.671.330.770.910.770.75
EPS Diluted 4.434.881.381.91-0.665.47-1.869.031.50.264.194.434.294.032.973.323.723.263.42.932.191.641.310.770.910.770.75
EBITDA 2,250.92,220.21,494.71,645.11,005.32,138.81,058.71,852.61,793.91,152.21,378.31,409.71,426.11,394.11,260.61,472.41,433.61,382.81,368.71,297.31,025.6644.8426.2271.7291.1253237
EBITDA Ratio 0.2930.30.2150.2410.1640.2680.1340.2370.2340.1920.2950.3050.3190.3130.2990.360.3480.3550.3920.3950.3440.3390.3110.2310.280.2690.275